- Home
- LVS vs IQV Comparison
LVS vs IQV Comparison
Compare LVS & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVS
- IQV
- Stock Information
- Founded
- LVS 1988
- IQV 1982
- Country
- LVS United States
- IQV United States
- Employees
- LVS N/A
- IQV N/A
- Industry
- LVS Hotels/Resorts
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- LVS Consumer Discretionary
- IQV Health Care
- Exchange
- LVS Nasdaq
- IQV Nasdaq
- Market Cap
- LVS 38.3B
- IQV 38.1B
- IPO Year
- LVS 2004
- IQV 2013
- Fundamental
- Price
- LVS $52.26
- IQV $197.41
- Analyst Decision
- LVS Buy
- IQV Strong Buy
- Analyst Count
- LVS 14
- IQV 17
- Target Price
- LVS $58.69
- IQV $255.88
- AVG Volume (30 Days)
- LVS 4.8M
- IQV 1.6M
- Earning Date
- LVS 01-22-2025
- IQV 02-12-2025
- Dividend Yield
- LVS 1.53%
- IQV N/A
- EPS Growth
- LVS 133.34
- IQV 27.98
- EPS
- LVS 2.02
- IQV 7.62
- Revenue
- LVS $11,317,000,000.00
- IQV $15,315,000,000.00
- Revenue This Year
- LVS $10.21
- IQV $3.11
- Revenue Next Year
- LVS $9.76
- IQV $4.58
- P/E Ratio
- LVS $25.88
- IQV $25.89
- Revenue Growth
- LVS 31.99
- IQV 3.10
- 52 Week Low
- LVS $36.62
- IQV $187.62
- 52 Week High
- LVS $56.61
- IQV $261.73
- Technical
- Relative Strength Index (RSI)
- LVS 49.52
- IQV 43.88
- Support Level
- LVS $50.91
- IQV $188.87
- Resistance Level
- LVS $53.93
- IQV $201.00
- Average True Range (ATR)
- LVS 1.34
- IQV 5.39
- MACD
- LVS -0.36
- IQV -0.05
- Stochastic Oscillator
- LVS 23.68
- IQV 40.38
About LVS Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore toward the end of 2028. Its Venetian and Palazzo Las Vegas assets in the U.S. were sold to Apollo and VICI in 2022. With the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.